Concepedia
Statistics
Publications
2
Citations
62
H-Index
Active since
2019
Affiliations
Pfizer (China)(Current)
Pfizer (United States)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Yuting Mu is an author at Pfizer (China) specializing in clinical pharmacology, diabetes mellitus, and adverse drug events.
Publications per year
2019–2019
Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia
Linong Ji, Yanmei Liu, Heng Miao et al. · Diabetes Obesity and Metabolism · 2019 · 52 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects
Yinhua Li, Yuting Mu, Haihong Shi et al. · Clinical Pharmacology in Drug Development · 2019 · 10 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +16
1–2 of 2